Cargando…

Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation

Histone deacetylases (HADC) are the enzymes that remove acetyl group from lysine residue of histones and non-histone proteins and regulate the process of transcription by binding to transcription factors and regulating fundamental cellular process such as cellular proliferation, differentiation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shukla, Surabhi, Tekwani, Babu L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194116/ https://www.ncbi.nlm.nih.gov/pubmed/32390854 http://dx.doi.org/10.3389/fphar.2020.00537

Ejemplares similares

Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases
por: Li, Jianglei, et al.
Publicado: (2022)

The effects of the histone deacetylase inhibitor 4-phenylbutyrate on gap junction conductance and permeability
por: Kaufman, Joshua, et al.
Publicado: (2013)

Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis
por: Parrella, Edoardo, et al.
Publicado: (2022)

Histone Deacetylase Inhibitor Alleviates the Neurodegenerative Phenotypes and Histone Dysregulation in Presenilins-Deficient Mice
por: Cao, Ting, et al.
Publicado: (2018)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Corrigendum: Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases
por: Li, Jianglei, et al.
Publicado: (2022)

The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification
por: Yao, Jingfang, et al.
Publicado: (2022)

Carbocisteine Improves Histone Deacetylase 2 Deacetylation Activity via Regulating Sumoylation of Histone Deacetylase 2 in Human Tracheobronchial Epithelial Cells
por: Song, Yun, et al.
Publicado: (2019)

Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
por: Akone, Sergi Herve, et al.
Publicado: (2020)

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
por: Zhou, Xun, et al.
Publicado: (2021)

Sirt6 Deacetylase: A Potential Key Regulator in the Prevention of Obesity, Diabetes and Neurodegenerative Disease
por: Raj, Swapnil, et al.
Publicado: (2020)

Histone Deacetylase SIRT1, Smooth Muscle Cell Function, and Vascular Diseases
por: Wang, Fang, et al.
Publicado: (2020)

Ferroptosis in Neurons and Cancer Cells Is Similar But Differentially Regulated by Histone Deacetylase Inhibitors
por: Zille, Marietta, et al.
Publicado: (2019)

Design of Diarylheptanoid Derivatives as Dual Inhibitors Against Class IIa Histone Deacetylase and β-amyloid Aggregation
por: Chen, Liang-Chieh, et al.
Publicado: (2018)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
por: Divsalar, Donya Naz, et al.
Publicado: (2020)

Histone deacetylase inhibitors modulate K(ATP) subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis
por: Fatima, Naheed, et al.
Publicado: (2015)

Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective
por: Kumar, Vishal, et al.
Publicado: (2022)

Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich's Ataxia: A New Synthetic Route
por: Xu, Chunping, et al.
Publicado: (2011)

Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence
por: Wang, Yiran, et al.
Publicado: (2023)

Discovery of N-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
por: Zhang, Lihui, et al.
Publicado: (2019)

Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
por: Kretsovali, Androniki, et al.
Publicado: (2012)

Mitoprotective Effects of Centella asiatica (L.) Urb.: Anti-Inflammatory and Neuroprotective Opportunities in Neurodegenerative Disease
por: Wong, Jia Hui, et al.
Publicado: (2021)

The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
por: Hassan, Syed Shams ul, et al.
Publicado: (2022)

Administration of a Histone Deacetylase Inhibitor into the Basolateral Amygdala Enhances Memory Consolidation, Delays Extinction, and Increases Hippocampal BDNF Levels
por: Valiati, Fernanda E., et al.
Publicado: (2017)

Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases
por: Tago, Tetsuro, et al.
Publicado: (2018)

Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside
por: Bian, Yaqi, et al.
Publicado: (2020)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Corrigendum: The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
por: Hassan, Syed Shams ul, et al.
Publicado: (2022)

Pain Modulation in WAG/Rij Epileptic Rats (A Genetic Model of Absence Epilepsy): Effects of Biological and Pharmacological Histone Deacetylase Inhibitors
por: De Caro, Carmen, et al.
Publicado: (2020)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours
por: Ellis, Samantha L. S., et al.
Publicado: (2023)

Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia/Reperfusion Injury
por: Pickell, Zachary, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors and Diabetic Kidney Disease
por: Hadden, Mitchell J., et al.
Publicado: (2018)

Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies
por: Yang, Jia, et al.
Publicado: (2020)

Histone deacetylase inhibition reduces cardiac connexin43 expression and gap junction communication
por: Xu, Qin, et al.
Publicado: (2013)

Selective Histone Deacetylase 6 Inhibitor 23BB Alleviated Rhabdomyolysis-Induced Acute Kidney Injury by Regulating Endoplasmic Reticulum Stress and Apoptosis
por: Feng, Yuying, et al.
Publicado: (2018)

Clinical Toxicities of Histone Deacetylase Inhibitors
por: Subramanian, Srividya, et al.
Publicado: (2010)

Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats
por: He, Xiao-Tao, et al.
Publicado: (2018)

Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis
por: Luque-Martin, Rosario, et al.
Publicado: (2019)

Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells
por: Zichittella, Chiara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_272f5147sf5u4s6nf880kh39g0